174 related articles for article (PubMed ID: 24996662)
21. Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider.
Upadhyay J; Rao NN; Upadhyay RB; Agarwal P
Asian Pac J Cancer Prev; 2011; 12(7):1757-60. PubMed ID: 22126560
[TBL] [Abstract][Full Text] [Related]
22. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
[TBL] [Abstract][Full Text] [Related]
23. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review.
Rashid A; Warnakulasuriya S
J Oral Pathol Med; 2015 May; 44(5):307-28. PubMed ID: 25183259
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
Nagaraju K; Prasad S; Ashok L
Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of autofluorescence and chemiluminescence in the diagnosis of oral Dysplasia and Carcinoma: A systematic review and Meta-analysis.
Moffa A; Giorgi L; Costantino A; De Benedetto L; Cassano M; Spriano G; Mercante G; De Virgilio A; Casale M
Oral Oncol; 2021 Oct; 121():105482. PubMed ID: 34399191
[TBL] [Abstract][Full Text] [Related]
26. Autofluorescence imaging to identify oral malignant or premalignant lesions: Systematic review and meta-analysis.
Kim DH; Kim SW; Hwang SH
Head Neck; 2020 Dec; 42(12):3735-3743. PubMed ID: 32866310
[TBL] [Abstract][Full Text] [Related]
27. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia.
Martin IC; Kerawala CJ; Reed M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Apr; 85(4):444-6. PubMed ID: 9574954
[TBL] [Abstract][Full Text] [Related]
28. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma.
Epstein JB; Oakley C; Millner A; Emerton S; van der Meij E; Le N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 May; 83(5):537-47. PubMed ID: 9159812
[TBL] [Abstract][Full Text] [Related]
29. How effective is toluidine blue for screening and diagnosis of oral cancer and premalignant lesions?
Mills S
Evid Based Dent; 2022 Mar; 23(1):34-35. PubMed ID: 35338328
[TBL] [Abstract][Full Text] [Related]
30. Toluidine blue: yet another low cost method for screening oral cavity tumour margins in third world countries.
Junaid M; Suhail A; Umer B; Nawaz A; Ikram M; Sobani ZU; Ali NS
J Pak Med Assoc; 2013 Jul; 63(7):835-7. PubMed ID: 23901703
[TBL] [Abstract][Full Text] [Related]
31. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.
Gupta A; Singh M; Ibrahim R; Mehrotra R
Acta Cytol; 2007; 51(5):788-94. PubMed ID: 17910350
[TBL] [Abstract][Full Text] [Related]
32. Comparison of toluidine blue 1% staining patterns in cytopathologically confirmed ocular surface squamous neoplasias and in non-neoplastic lesions.
Aliakbar Navahi R; Hosseini SB; Kanavi MR; Rakhshani N; Aghaei H; Kheiri B
Ocul Surf; 2019 Jul; 17(3):578-583. PubMed ID: 31054321
[TBL] [Abstract][Full Text] [Related]
33. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions.
Mehrotra R; Singh M; Thomas S; Nair P; Pandya S; Nigam NS; Shukla P
J Am Dent Assoc; 2010 Feb; 141(2):151-6. PubMed ID: 20123872
[TBL] [Abstract][Full Text] [Related]
34. Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading.
Zaini ZM; McParland H; Møller H; Husband K; Odell EW
Sci Rep; 2018 Oct; 8(1):15874. PubMed ID: 30367100
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the frequency of micronuclei in exfoliated cells from oral lesions previously identified by toluidine blue.
Francielli de Oliveira P; Faria Andrade A; Ferreira Malheiros F; Aparecida de Lacerda S; Aparecida Campos A; Zaia JE; de Oliveira Cecchi A
Acta Cytol; 2011; 55(4):344-9. PubMed ID: 21791904
[TBL] [Abstract][Full Text] [Related]
36. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.
Warnakulasuriya KA; Johnson NW
J Oral Pathol Med; 1996 Mar; 25(3):97-103. PubMed ID: 9148038
[TBL] [Abstract][Full Text] [Related]
38. Acetic acid versus toluidine blue as screening tools for oral potentially malignant disorders.
Winton Kalluvelil SR; Narayanan VS
Indian J Cancer; 2023; 60(3):427-431. PubMed ID: 36861696
[TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of autofluorescence imaging and histopathological investigation for oral potentially malignant disorders in Taiwan.
Chiang TE; Lin YC; Li YH; Wu CT; Kuo CS; Chen YW
Clin Oral Investig; 2019 May; 23(5):2395-2402. PubMed ID: 30302607
[TBL] [Abstract][Full Text] [Related]
40. Comparison of different screening methods in estimating the prevalence of precancer and cancer amongst male inmates of a jail in maharashtra, India.
Chaudhari A; Hegde-Shetiya S; Shirahatti R; Agrawal D
Asian Pac J Cancer Prev; 2013; 14(2):859-64. PubMed ID: 23621252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
